Compare of FEV1 and FEV1/FVC after use fluticasone/salmeterol in the form of MDI and DPI for the treatment of children's asthma

Compare of Forced Expiratory Volume in 1 second (FEV1) and FEV1/Forced Vital Capacity(FVC) after use fluticasone/salmeterol in the form of Metered-dose Injaler (MDI) and Dry Powder Inhaler( DPI) for the treatment of children's asthma.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220812055665N2

Enrollment

Registered

2025-10-07

Start date

2023-04-21

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma. Other and unspecified asthma

Interventions

Intervention 1: Intervention group: In this group, the combination of fluticasone/salmeterol inhaler in the form of MDI is used every 12 hours at the dose required by the patient for one month, in the

Eligibility

Sex/Gender

All

Age

6 Years to No maximum

Inclusion criteria

Inclusion criteria: Children over 6 years with moderate asthma requiring therapy with ICS/LABA stable condition Parental consent

Exclusion criteria

Exclusion criteria: Unstable condition

Design outcomes

Primary

Measure	Time frame
Forced Expiratory Volume in 1 second (FEV1). Timepoint: beginning of the study , One month after starting teatment , One month after starting treatment. Method of measurement: Spirometry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohre Akbari Jokar

Shahid Beheshti University of Medical Sciences

zohreakbari2351@yahoo.com+98 21 2243 9770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026